Cross-linking of CD80 on CD4+ T cells activates a calcium-dependent signaling pathway

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 766-773

  Podoji, Joseph R ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CALCIUM; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD80; PROTEIN BCL XL; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; CROSS LINKING REAGENT; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; FEMALE; INTRON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TH1 CELL; UPREGULATION; ANIMAL; ANTIBODY COMBINING SITE; BIOSYNTHESIS; C57BL MOUSE; CALCIUM SIGNALING; CELL CULTURE; COMPARATIVE STUDY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; SECRETION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD80; BINDING SITES, ANTIBODY; CALCIUM SIGNALING; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-LINKING REAGENTS; FEMALE; INTERFERON-GAMMA; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-BOX DOMAIN PROTEINS; TH1 CELLS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 60549110302     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.766     Document Type: Article

References (51)

1. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262: 905-907.
2. Lenschow, D. J., G. H. Su, L. A. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90: 11054-11058.
3. + T lymphocytes. J. Immunol. 148: 1985-1992.
4. Norton, S. D., L. Zuckerman, K. B. Urdahl, R. Shefner, J. Miller, and M. K. Jenkins. 1992. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J. Immunol. 149: 1556-1561.
5. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184: 783-788.
6. Perrin, P. J., D. Scott, T. A. Davis, G. S. Gray, M. J. Doggett, R. Abe, C. H. June, and M. K. Racke. 1996. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis. J. Neuroimmunol. 65: 31-39.
7. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5: 285-293.
8. Lenschow, D. J., Y. Zeng, K. S. Hathcock, L. A. Zuckerman, G. Freeman, J. R. Thistlethwaite, G. S. Gray, R. J. Hodes, and J. A. Bluestone. 1995. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibody. Transplantation 60: 1171-1178.
9. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257: 789-792.
10. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
11. + T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis. J. Immunol. 177: 2948-2958.
12. Suvas, S., V. Singh, S. Sahdev, H. Vohra, and J. N. Agrewala. 2002. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 277: 7766-7775.
13. Orabona, C., U. Grohmann, M. L. Belladonna, F. Fallarino, C. Vacca, R. Bianchi, S. Bozza, C. Volpi, B. T. Salomon, M. C. Fioretti, L. Romani, and P. Puccetti. 2004. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5: 1134-1142.
14. Nickoloff, B. J., F. O. Nestle, X. G. Zheng, and L. A. Turka. 1994. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Blood 83: 2580-2586.
15. Taylor, P. A., C. J. Lees, S. Fournier, J. P. Allison, A. H. Sharpe, and B. R. Blazar. 2004. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172: 34-39.
16. Shnyreva, M., W. M. Weaver, M. Blanchette, S. L. Taylor, M. Tompa, D. R. Fitzpatrick, and C. B. Wilson. 2004. Evolutionarily conserved sequence elements that positively regulate IFN-γ expression in T cells. Proc. Natl. Acad. Sci. USA 101: 12622-12627.
17. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
18. Patrone, G., F. Puppo, R. Cusano, M. Scaranari, I. Ceccherini, A. Puliti, and R. Ravazzolo. 2000. Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR. BioTechniques 29: 1012-1017.
19. Podojil, J. R., N. W. Kin, and V. M. Sanders. 2004. CD86 and β2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3′-IgH enhancer in B cells. J. Biol. Chem. 279: 23394-23404.
20. Avni, O., D. Lee, F. Macian, S. J. Szabo, L. H. Glimcher, and A. Rao. 2002. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3: 643-651.
21. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
22. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149: 380-388.
23. Linsley, P. S., J. Bradshaw, M. Urnes, L. Grosmaire, and J. A. Ledbetter. 1993. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J. Immunol. 150: 3161-3169.
24. Wyss-Coray, T., D. Mauri-Hellwg, K. Baumann, F. Bettens, R. Grunow, and W. J. Pichler. 1993. The B-7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T interactions. Eur. J. Immunol. 23: 2175-2180.
25. + T cells via IL-2 dependent mechanisms. Cell Immunol. 235: 56-64.
26. Hwang, E. S., S. J. Szabo, P. L. Schwartzberg, and L. H. Glimcher. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307: 430-433.
27. Chan, S. H., M. Kobayashi, D. Santoli, B. Perussia, and G. Trinchieri. 1992. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/ IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148: 92-98.
28. Cho, J. Y., V. Grigura, T. L. Murphy, and K. Murphy. 2003. Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-γ promoter. Int. Immunol. 15: 1149-1160.
29. Schaeffer, E. M., J. Debnath, G. Yap, D. McVicar, X. C. Liao, D. R. Littman, A. Sher, H. E. Varmus, M. J. Lenardo, and P. L. Schwartzberg. 1999. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284: 638-641.
30. Liu, K. Q., S. C. Bunnell, C. B. Gurniak, and L. J. Berg. 1998. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187: 1721-1727.
31. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313.
32. Doty, R. T., and E. A. Clark. 1996. Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation. J. Immunol. 157: 3270-3279.
33. Hirokawa, M., J. Kuroki, A. Kitabayashi, and A. B. Miura. 1996. Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation. Immunol. Lett. 50: 95-98.
34. Khan, N., S. Ghousunnissa, S. M. Jegadeeswaran, D. Thiagarajan, S. E. Hasnain, and S. Mukhopadhyay. 2007. Anti-B7-1/B7-2 antibody elicits innate-effector responses in macrophages through NF-κB-dependent pathway. Int. Immunol. 19: 477-486.
35. Jackman, R. P., F. Balamuth, and K. Bottomly. 2007. CTLA-4 differentially regulates the immunological synapse in CD4 T cell subsets. J. Immunol. 178: 5543-5551.
36. Balamuth, F., J. L. Brogdon, and K. Bottomly. 2004. CD4 raft association and signaling regulate molecular clustering at the immunological synapse site. J. Immunol. 172: 5887-5892.
37. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363: 156-159.
38. Gajewski, T. F., S. R. Schell, and F. W. Fitch. 1990. Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J. Immunol. 144: 4110-4120.
39. 2+ clearance distinguish Th1 and Th2 lymphocytes. J. Immunol. 164: 1153-1160.
40. Linsley, P. S., J. Bradshaw, J. Green, R. Peach, K. L. Bennett, and R. S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4: 535-543.
41. + T lymphocytes. J. Immunol. 169: 6231-6235.
42. Stephan, M. T., V. Ponomarev, R. J. Brentjens, A. H. Chang, K. V. Dobrenkov, G. Heller, and M. Sadelain. 2007. T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nat. Med. 13: 1440-1449.
43. Karandikar, N. J., C. L. Vanderlugt, T. N. Eagar, L. Tan, J. A. Bluestone, and S. D. Miller. 1998. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161: 192-199.
44. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3: 739-745.
45. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD80), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182: 1985-1996.
46. Kantarci, O. H., D. D. Hebrink, S. J. Achenbach, E. J. Atkinson, A. Waliszewska, G. Buckle, C. T. McMurray, M. de Andrade, D. A. Hafler, and B. G. Weinshenker. 2003. CTLA4 is associated with susceptibility to multiple sclerosis. J. Neuroimmunol. 134: 133-141.
47. Gribben, J. G., G. J. Freeman, V. A. Boussiotis, P. Rennert, C. L. Jellis, E. Greenfield, M. Barber, V. A. Resvito, X. Ke, G. S. Gray, and L. M. Nadler. 1995. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92: 811-815.
48. Boise, L. H., P. J. Noel, and C. B. Thompson. 1995. CD28 and apoptosis. Curr. Opin. Immunol. 7: 620-625.
49. Fallarino, F., P. E. Fields, and T. F. Gajewski. 1998. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188: 205-210.
50. Azuma, H., A. Chandraker, K. Nadeau, W. W. Hancock, C. B. Carpenter, N. L. Tilney, and M. H. Sayegh. 1996. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc. Natl. Acad. Sci. USA 93: 12439-12444.
51. + T lymphocytes from TCR transgenic mice. J. Immunol. 152: 5220-5225.